Bausch Health Companies (BHC) Asset Utilization Ratio (2010 - 2026)
Bausch Health Companies' (BHC) quarterly Asset Utilization Ratio came in at 0.44 in Q2 2026, up 19.91% year-over-year from 0.37 in Q2 2025, and up 6.34% quarter-over-quarter from 0.41 in Q1 2026.
Analysis
Bausch Health Companies (BHC) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Asset Utilization Ratio across 17 years of filings, most recently posting 0.44 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 19.91% year-over-year to 0.44; the TTM figure through Jun 2026 stood at 0.44 (up 19.91% YoY), while the FY2025 annual figure was 0.39, up 8.64% from the prior year.
- Asset Utilization Ratio came in at 0.44 for Q2 2026 at Bausch Health Companies, up from 0.41 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.44 in Q2 2026 to a low of 0.29 in Q1 2022.
- Average Asset Utilization Ratio over 5 years is 0.35, with a median of 0.34 recorded in 2024.
- Year-over-year, Asset Utilization Ratio climbed 1.65% in 2022 and gained 19.91% in 2026.
- Over 5 years, Asset Utilization Ratio stood at 0.31 in 2022, then grew by 2.98% to 0.32 in 2023, then climbed by 12.71% to 0.36 in 2024, then advanced by 6.41% to 0.39 in 2025, then rose by 14.08% to 0.44 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.44 in Q2 2026, 0.41 in Q1 2026, and 0.39 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 0.43 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.41 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 0.59 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 0.85 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 0.44 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 0.67 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 0.43 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 0.73 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.44 |
| Mar 31, 2026 | 0.41 |
| Dec 31, 2025 | 0.39 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.37 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.36 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.33 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.29 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.29 |